Form 8-K - Current report:
SEC Accession No. 0001437749-21-008218
Filing Date
2021-04-05
Accepted
2021-04-05 16:09:14
Documents
2
Period of Report
2021-04-02
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K navb20210405_8k.htm 8-K 32262
2 EXHIBIT 3.1 ex_239143.htm EX-3.1 21875
  Complete submission text file 0001437749-21-008218.txt   55408
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35076 | Film No.: 21805418
SIC: 2835 In Vitro & In Vivo Diagnostic Substances